-
1
-
-
84930531402
-
Gene-panel sequencing and the prediction of breast-cancer risk
-
1 Easton, D.F., Pharoah, P.D., Antoniou, A.C., et al. Gene-panel sequencing and the prediction of breast-cancer risk. N Engl J Med 372 (2015), 2243–2257.
-
(2015)
N Engl J Med
, vol.372
, pp. 2243-2257
-
-
Easton, D.F.1
Pharoah, P.D.2
Antoniou, A.C.3
-
2
-
-
73949135028
-
Monoallelic and biallelic inactivation of TP53 gene in chronic lymphocytic leukemia: selection, impact on survival, and response to DNA damage
-
2 Malcikova, J., Smardova, J., Rocnova, L., et al. Monoallelic and biallelic inactivation of TP53 gene in chronic lymphocytic leukemia: selection, impact on survival, and response to DNA damage. Blood 114 (2009), 5307–5314.
-
(2009)
Blood
, vol.114
, pp. 5307-5314
-
-
Malcikova, J.1
Smardova, J.2
Rocnova, L.3
-
3
-
-
84864255882
-
The origin and evolution of mutations in acute myeloid leukemia
-
3 Welch, J.S., Ley, T.J., Link, D.C., et al. The origin and evolution of mutations in acute myeloid leukemia. Cell 150 (2012), 264–278.
-
(2012)
Cell
, vol.150
, pp. 264-278
-
-
Welch, J.S.1
Ley, T.J.2
Link, D.C.3
-
4
-
-
84920024296
-
Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence
-
4 Genovese, G., Kahler, A.K., Handsaker, R.E., et al. Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence. N Engl J Med 371 (2014), 2477–2487.
-
(2014)
N Engl J Med
, vol.371
, pp. 2477-2487
-
-
Genovese, G.1
Kahler, A.K.2
Handsaker, R.E.3
-
5
-
-
84925518008
-
Role of TP53 mutations in the origin and evolution of therapy-related acute myeloid leukaemia
-
5 Wong, T.N., Ramsingh, G., Young, A.L., et al. Role of TP53 mutations in the origin and evolution of therapy-related acute myeloid leukaemia. Nature 518 (2015), 552–555.
-
(2015)
Nature
, vol.518
, pp. 552-555
-
-
Wong, T.N.1
Ramsingh, G.2
Young, A.L.3
-
6
-
-
84920053873
-
Age-related clonal hematopoiesis associated with adverse outcomes
-
6 Jaiswal, S., Fontanillas, P., Flannick, J., et al. Age-related clonal hematopoiesis associated with adverse outcomes. N Engl J Med 371 (2014), 2488–2498.
-
(2014)
N Engl J Med
, vol.371
, pp. 2488-2498
-
-
Jaiswal, S.1
Fontanillas, P.2
Flannick, J.3
-
7
-
-
84930003179
-
Age-related mutations associated with clonal hematopoietic expansion and malignancies
-
7 Xie, M., Lu, C., Wang, J., et al. Age-related mutations associated with clonal hematopoietic expansion and malignancies. Nat Med 20 (2014), 1472–1478.
-
(2014)
Nat Med
, vol.20
, pp. 1472-1478
-
-
Xie, M.1
Lu, C.2
Wang, J.3
-
8
-
-
84973288294
-
Genetic/Familial High-Risk Assessment: Breast and Ovarian. Version 2.2016
-
NCCN Clinical Practice Guidelines in Oncology [Internet]. 2016 March 3; Available at
-
8 Daly, M., Pilarski, R., Axilbund, J.E., et al. Genetic/Familial High-Risk Assessment: Breast and Ovarian. Version 2.2016. NCCN Clinical Practice Guidelines in Oncology [Internet]. 2016 March 3; Available at http://www.nccn.org/professionals/physician_gls/pdf/genetics_screening.pdf, 2016.
-
(2016)
-
-
Daly, M.1
Pilarski, R.2
Axilbund, J.E.3
-
9
-
-
84926610163
-
Development and analytical validation of a 25-gene next generation sequencing panel that includes the BRCA1 and BRCA2 genes to assess hereditary cancer risk
-
9 Judkins, T., Leclair, B., Bowles, K., et al. Development and analytical validation of a 25-gene next generation sequencing panel that includes the BRCA1 and BRCA2 genes to assess hereditary cancer risk. BMC Cancer, 15, 2015, 215.
-
(2015)
BMC Cancer
, vol.15
, pp. 215
-
-
Judkins, T.1
Leclair, B.2
Bowles, K.3
-
10
-
-
84940449545
-
Multigene panel testing detects equal rates of pathogenic BRCA1/2 mutations and has a higher diagnostic yield compared to limited BRCA1/2 analysis alone in patients at risk for hereditary breast cancer
-
10 Kapoor, N.S., Curcio, L.D., Blakemore, C.A., et al. Multigene panel testing detects equal rates of pathogenic BRCA1/2 mutations and has a higher diagnostic yield compared to limited BRCA1/2 analysis alone in patients at risk for hereditary breast cancer. Ann Surg Oncol 22 (2015), 3282–3288.
-
(2015)
Ann Surg Oncol
, vol.22
, pp. 3282-3288
-
-
Kapoor, N.S.1
Curcio, L.D.2
Blakemore, C.A.3
-
11
-
-
84945468475
-
Patients tested at a laboratory for hereditary cancer syndromes show an overlap for multiple syndromes in their personal and familial cancer histories
-
11 Saam, J., Arnell, C., Theisen, A., et al. Patients tested at a laboratory for hereditary cancer syndromes show an overlap for multiple syndromes in their personal and familial cancer histories. Oncology 89 (2015), 288–293.
-
(2015)
Oncology
, vol.89
, pp. 288-293
-
-
Saam, J.1
Arnell, C.2
Theisen, A.3
-
12
-
-
84918798338
-
Frequency of mutations in individuals with breast cancer referred for BRCA1 and BRCA2 testing using next-generation sequencing with a 25-gene panel
-
12 Tung, N., Battelli, C., Allen, B., et al. Frequency of mutations in individuals with breast cancer referred for BRCA1 and BRCA2 testing using next-generation sequencing with a 25-gene panel. Cancer 121 (2015), 25–33.
-
(2015)
Cancer
, vol.121
, pp. 25-33
-
-
Tung, N.1
Battelli, C.2
Allen, B.3
-
13
-
-
84965051096
-
Frequency of germline mutations in 25 cancer susceptibility genes in a sequential series of patients with breast cancer
-
13 Tung, N., Lin, N.U., Kidd, J., et al. Frequency of germline mutations in 25 cancer susceptibility genes in a sequential series of patients with breast cancer. J Clin Oncol 34 (2016), 1460–1468.
-
(2016)
J Clin Oncol
, vol.34
, pp. 1460-1468
-
-
Tung, N.1
Lin, N.U.2
Kidd, J.3
-
14
-
-
84939839583
-
Identification of a variety of mutations in cancer predisposition genes in patients with suspected lynch syndrome
-
14 Yurgelun, M.B., Allen, B., Kaldate, R.R., et al. Identification of a variety of mutations in cancer predisposition genes in patients with suspected lynch syndrome. Gastroenterology 149 (2015), 604–613.
-
(2015)
Gastroenterology
, vol.149
, pp. 604-613
-
-
Yurgelun, M.B.1
Allen, B.2
Kaldate, R.R.3
-
15
-
-
0036071261
-
The diagnostic applications of saliva—a review
-
15 Kaufman, E., Lamster, I.B., The diagnostic applications of saliva—a review. Crit Rev Oral Biol Med 13 (2002), 197–212.
-
(2002)
Crit Rev Oral Biol Med
, vol.13
, pp. 197-212
-
-
Kaufman, E.1
Lamster, I.B.2
|